Bayer (FRA:BAYN)‘s stock had its “buy” rating restated by research analysts at JPMorgan Chase & Co. in a research note issued to investors on Thursday.

Several other equities research analysts have also recently commented on the stock. Jefferies Financial Group set a €77.00 ($89.53) price target on shares of Bayer and gave the stock a “neutral” rating in a research report on Thursday. Baader Bank set a €123.00 ($143.02) price target on shares of Bayer and gave the stock a “buy” rating in a research report on Thursday. Commerzbank set a €111.00 ($129.07) price target on shares of Bayer and gave the stock a “buy” rating in a research report on Thursday. Goldman Sachs Group set a €111.00 ($129.07) price target on shares of Bayer and gave the stock a “buy” rating in a research report on Thursday. Finally, UBS Group set a €122.00 ($141.86) price objective on shares of Bayer and gave the company a “buy” rating in a report on Wednesday. Seven research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of €98.80 ($114.88).

Shares of FRA:BAYN opened at €76.10 ($88.49) on Thursday. Bayer has a one year low of €91.58 ($106.49) and a one year high of €123.82 ($143.98).

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Read More: What is a stock split?

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.